Graves 病复发影响因素研究

陈 芋澄, 韦 华
右江民族医学院

摘要

目的：Graves病（Graves’ disease，GD）是一种常见的自身免疫性甲状腺疾病。尽管目前治疗方法明确，但复发率仍较高。
本文通过对近年来国内外研究文献的分析，对 Graves 病复发的影响因素进行了综述，并对该领域的最新研究进展进行讨论。

关键词

Graves 病；复发；影响因素；研究进展

参考

[1]Le Moli R, Malandrino P, Russo M, et al. Corticosteroid Pulse Therapy for Graves’ Ophthalmopathy Reduces the Relapse Rate of Graves’ Hyperthyroidism[J]. Front Endocrinol (Lausanne), 2020,11:367.

[2] Chung J H. Antithyroid Drug Treatment in Graves’ Disease[J]. Endocrinol Metab (Seoul), 2021,36(3):491-499.

[3] 中华医学会内分泌学分会中国甲状腺疾病诊治指南编写组 . 中国甲状腺疾病诊治指南 —— 甲状腺功能亢进症[J]. 中华内科杂志 ,2007,46(10):876-882.

[4]Jiang X, Hu H, Fu Z, et al. ASSOCIATION BETWEEN THE CTLA-4 EXON 1+49A/G POLYMORPHISM AND THE RELAPSE OF GRAVE’S DISEASE AFTER ATD WITHDRAWAL: A META-ANALYSIS[J]. Acta Endocrinol(Buchar), 2022,18(3):324-332.

[5]Yao Q, Song Z, Wang B, et al. Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease[J]. Front Cell Dev Biol, 2021,9:756560.

[6] 王月桂 , 洪理伟 , 吕国荣 , 等 . 超声联合 Ki67 分析Graves 病患者 131I 治疗后甲亢未愈或复发的相关因素 [J].南方医科大学学报 ,2022,42(12):1902-1906.

[7] Benvenga S, Elia G, Ragusa F, et al. Endocrine disruptors and thyroid autoimmunity[J]. Best Pract Res Clin Endocrinol Metab, 2020,34(1):101377.

[8] Chen D W, Yeh M W. Disparities in Thyroid Care[J].Endocrinol Metab Clin North Am, 2022,51(2):229-241.

[9] 王卫民 . 积极心理干预对甲状腺功能亢进患者焦虑、抑郁情绪的影响 [J]. 中国健康心理学杂志 ,2020,28(01):83-86.

[10] Vaivode I, Zake T, Strele I, et al. Stress-Related Immune Response and Selenium Status in Autoimmune Thyroid Disease Patients[J]. Int J Mol Sci, 2023,24(3).

[11] 李利利 . 压力管理方案对抑郁症患者病情控制、应对方式的影响 [J]. 罕少疾病杂志 ,2021,28(01):81-83.

[12] 吴秀平 , 黄清云 . 甲状腺功能亢进症患者自我效能感与用药依从性的调查分析 [J]. 中国医药科学 ,2022,12(14):110-113.

[13]Gorini F, Sabatino L, Pingitore A, et al. Selenium: An Element of Life Essential for Thyroid Function[J]. Molecules, 2021,26(23).

[14]Cho Y Y, Chung Y J. Vitamin D supplementation does not prevent the recurrence of Graves’ disease[J]. Sci Rep, 2020,10(1):16.

[15] 夏秦 . 儿童 Graves 病的血清非靶向代谢组学研究[D]. 苏州大学 ,2021.

[16]Bostan H, Ucan B, Kizilgul M, et al. Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature[J]. J Autoimmun, 2022,128:102809.

[17]Cao J, Wang N, Luo Y, et al. A cause-effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid-gut axis: A bidirectional two-sample Mendelian randomization study[J]. Front Immunol, 2023,14:977587.